Etiology of travel-related fever

Current Opinion in Infectious Diseases

Volumn 20, Issue 5, 2007, Pages 449-453

  Wilson, Mary E ^a,c,d   Freedman, David O ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT AUBURN HOSPITAL   (United States)

^c University of Alabama at Birmingham   (United States)

^d NONE   (United States)

Author keywords

Chikungunya; Fever; Ill returned travelers; Malaria

Indexed keywords

AFRICA; CHIKUNGUNYA ALPHAVIRUS; DENGUE; FEVER; GEOGRAPHY; HUMAN; INDIAN OCEAN; MALARIA; MORBIDITY; PARASITOSIS; PRIMARY INFECTION; RELAPSE; REVIEW;

ALPHAVIRUS INFECTIONS; CHIKUNGUNYA VIRUS; FEVER; HUMANS; INFECTION; MALARIA; TRAVEL;

EID: 34548401139     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282a95e27     Document Type: Review

References (28)

1. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002; 347:505-516.
2. Wilson ME, Weld LH, Boggild A, et al. Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44:1560-1568. The authors describe causes of fever by place of exposure and traveler characteristics in almost 7000 returned travelers with fever.
3. Bottieau E, Clerinx J, Schrooten W, et al. Etiology and outcome of fever after a stay in the tropics. Arch Intern Med 2006; 166:1642-1648. This was a large study (n = 1743) of inpatients and outpatients of all ages with fever within a year of a stay in the tropics seen at referral centers in Antwerp, Belgium.
4. Bottieau E, Clerinx J, Van den Enden E, et al. Infectious mononucleosis-like syndromes in febrile travelers returned from the topics. J Travel Med 2006; 13:191-197.
5. Parola P, Soula G, Gazin P, et al. Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999-2003. Travel Med Infect Dis 2006; 4:61-70.
6. Ansart S, Perez L, Vergely O, et al. Illnesses in travelers returning from the tropics: a prospective study of 622 patients. J Travel Med 2005; 12:312-318.
7. Fenner L, Weber R, Steffen R, Schlagenhauf P. Imported infectious disease and purpose of travel, Switzerland. Emerg Infect Dis 2007; 13:217-222.
8. Stienlauf S, Segal G, Sidi Y, Schwartz E. Posttravel related hospitalization, in Israel. J Travel Med 2005; 12:136-141.
9. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relationship to place of exposure in ill returned travelers. N Engl J Med 2006; 354:119-130. This key paper describes spectrum of disease by geographic region of exposure in ill returned travelers. The paper includes a table showing destination-specific differences in diagnoses, and the figure displays proportionate morbidity by region of travel in ill returned travelers.
10. Baas MC, Wetsteyn MCFM, van Gool T. Patterns of imported malaria at the academic medical center, Amsterdam, The Netherlands. J Travel Med 2006; 13:2-7.
11. Bottieau E, Clerinx J, de Vega MR, et al. Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect 2006; 52:339-345. Authors describe 23 patients with Katayama fever who were infected in Africa.
12. Enk MJ, Amorim A, Schall VT. Acute schistosomiasis outbreak in the metropolitan area of Belo Horizonte, Minas Gerais: alert about the risk of unnoticed transmission increased by growing rural tourism. Mem Inst Oswaldo Cruz 2003; 98:745-750.
13. Meltzer E, Artom G, Marva E, et al. Schistosomiasis among travelers: new aspects of an old disease. Emerg Infect Dis 2006; 12:1696-1700. This paper describes schistosomiasis among Israeli travelers and shows the progression and outcome over time. It provides a useful framework for thinking about acute and chronic schistosomiasis in travelers.
14. Leder K, Tong S, Weld L, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006; 43:1185-1193. This study defined differential risk of certain illnesses in primary immigrants visiting friends and relatives in the country of origin when compared to those born in the new country of residence.
15. Schwartz E, Parise M, Kozarsky P, Cetron M. Delayed onset of malaria-implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349:1510-1516.
16. Imwong M, Snounou S, Pukrittayakamee S, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis 2007; 195:927-933. This was an important study in defining nature of relapse in vivax malaria. Individuals with vivax malaria are infected with genetically distinct populations of parasites.
17. Chen N, Auliff A, Rieckmann K, et al. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J Infect Dis 2007; 195:934-941. This was another important study that helped to define the nature of relapse in vivax malaria.
18. Collins WE. Further understanding the nature of relapse of Plasmodium vivax infection. J Infect Dis 2006; 195:919-920.
19. Goller JE, Jolley D, Ringwald P, Biggs B-A. Regional differences in the response of Plasmodium vivax malaria to primaquine as antirelapse therapy. Am J Trop Med Hyg 2007; 76:203-207.
20. Baird JK. A rare glimpse at the efficacy of primaquine. Am J Trop Med Hyg 2007; 76:201-202.
21. Hill DR, Baird K, Parise ME, et al. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 2006; 75:402-415.
22. Bottieau E, Clerinx J, van den Enden E, van Esbroeck M, et al. Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am J Trop Med Hyg 2006; 75:133-138. The authors describe clinical and laboratory findings in 98 cases of single-species infections caused by P. vivax, P. ovale, or P. malariae.
23. Hemmer CJ, Holst FGE, Kern P, et al. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006; 11:817-823.
24. Anstey NM, Handojo T, Pain MCF, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 2007; 195:589-596. The investigators study respiratory symptoms and pathophysiologic responses in Indonesian adults with uncomplicated vivax and falciparum malaria. This important study tries to identify mechanisms of lung injury in vivax malaria.
25. Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks: the globalization of vectorborne diseases. N Engl J Med 2007; 356:769-771. This is a succinct overview of the global situation.
26. CDC. Update: Chikungunya fever diagnoses among international travelers: United States, 2006. Morb Mortal Weekly Reports 2007; 56:276-277.
27. Hochedez P, Jaureguiberry S, Debruyne M, et al. Chikungunya infection in travelers. Emerg Infect Dis 2006; 12:1565-1567. This includes a photograph of skin rash.
28. Parola P, de Lamballerie X, Journda J, et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 2006; 12:1493-1499. This describes clinical and virologic findings.